Companies
Kenvue
S&P 500Consumer Staples· USA

KVUE

Status-Quo-Player

Kenvue

$17.26

-0.63%

Open $17.25·Prev $17.37

as of 13 Apr

STATUS-QUO-PLAYER

Power Core

Kenvue's moat is the compounding effect of healthcare-adjacent brand trust across categories where consumers conflate familiarity with clinical credibility.

Published1 Apr 2026
UniverseS&P 500
SectorConsumer Staples

Direction of Movement

Stable Absolute Position Masking Relative Competitive Erosion

ROC 200

-20.8%

Referenced in 1 other analysis

Company Profile

Kenvue Inc. is the world's largest pure-play consumer health company, specializing in science-backed products for everyday care needs. It operates through three key segments: Self Care, offering cough, cold, allergy, pain, digestive health, smoking cessation, and eye care under brands like Tylenol, Motrin, Benadryl, Nicorette, and Zyrtec; Skin Health and Beauty, providing face, body, hair, sun, and other care items via Neutrogena, Aveeno, Rogaine, and OGX; and Essential Health, delivering oral, baby, women's health, wound care, and related products through Listerine, Johnson's, Band-Aid, and Stayfree. Kenvue serves consumers in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America, focusing on trusted, iconic brands that support daily rituals and critical moments with innovation rooted in clinical research and consumer insights. Incorporated in 2022 and headquartered in Summit, New Jersey, Kenvue emphasizes integrity, quality, and solutions endorsed by healthcare professionals across diverse categories like pain relief, skin care, and oral health.

Sector

Consumer Defensive

Industry

Household & Personal Products

Employees

21,780

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.